ADMA Biologics Inc — Liquidità (NASDAQ:ADMA) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -102 M-112.37 M-59.51 M8.8 M118.67 M50.4 M 50.4 M Flussi di cassa derivanti dalle attività di investimento -12.72 M-13.51 M-13.91 M-4.98 M-8.57 M-21.89 M -21.89 M Liquidità derivante dalle attività di finanziamento 143.9 M121.05 M108.85 M-38.99 M-58.3 M-44.02 M -44.02 M Liquidità libera -114.73 M-125.88 M-73.42 M3.82 M110.1 M27.5 M 27.5 M

Notizie

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Adma Biologics (ADMA) Laps the Stock Market: Here's Why

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?

NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio

Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study

ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Upgrade)

Novartis Bolsters Immunology Pipeline With Excellergy Deal

Novo Nordisk's Awiqli Gets FDA Approval for Type II Diabetes

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate